Literature DB >> 26560854

The role of hypoxia in pancreatic cancer: a potential therapeutic target?

Mert Erkan1, Metin Kurtoglu2, Jorg Kleeff3,4.   

Abstract

One of the key factors that correlates with poor survival of patients with pancreatic cancer is the extent of hypoxic areas within the tumor tissue. The adaptation of pancreatic cancer cells to limited oxygen delivery promotes the induction of an invasive and treatment-resistant phenotype, triggering metastases at an early stage of tumor development, which resist in most cases adjuvant therapies following tumor resection. In this article, the authors summarize the evidence demonstrating the significance of hypoxia in pancreatic cancer pathogenesis and discuss the possible hypoxia-induced mechanisms underlying its aggressive nature. We then conclude with promising strategies that target hypoxia-adapted pancreatic cancer cells.

Entities:  

Keywords:  PEGPH20; Pancreatic cancer; TH-302; cancer stem cell; desmoplasia; epithelial-to-mesenchymal transition; hypoxia; metabolism

Mesh:

Substances:

Year:  2015        PMID: 26560854     DOI: 10.1586/17474124.2016.1117386

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  49 in total

1.  Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression.

Authors:  Avinoam Nevler; Samantha Z Brown; David Nauheim; Carla Portocarrero; Ulrich Rodeck; Jonathan Bassig; Christopher W Schultz; Grace A McCarthy; Harish Lavu; Theresa P Yeo; Charles J Yeo; Jonathan R Brody
Journal:  J Am Coll Surg       Date:  2020-02-11       Impact factor: 6.113

2.  p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity.

Authors:  Carolina Torres; Georgina Mancinelli; Jose Cordoba-Chacon; Navin Viswakarma; Karla Castellanos; Sam Grimaldo; Sandeep Kumar; Daniel Principe; Matthew J Dorman; Ronald McKinney; Emilio Hirsch; David Dawson; Hidayatullah G Munshi; Ajay Rana; Paul J Grippo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-02       Impact factor: 11.205

3.  NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1.

Authors:  Weilin Mao; Lei Zhang; Yefei Rong; Tiantao Kuang; Dansong Wang; Xuefeng Xu; Wenhui Lou; Jianang Li
Journal:  Dig Dis Sci       Date:  2022-09-13       Impact factor: 3.487

4.  Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma.

Authors:  Vikneshwari Natarajan; Sangdeuk Ha; Alexander Delgado; Reed Jacobson; Lina Alhalhooly; Yongki Choi; Jiha Kim
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

5.  Hypoxia-Related Signature Is a Prognostic Biomarker of Pancreatic Cancer.

Authors:  Jing-Jing Zhang; Chao Shao; Yi-Xin Yin; Qiang Sun; Ya-Ni Li; Ya-Wen Zha; Min-Ying Li; Bang-Li Hu
Journal:  Dis Markers       Date:  2022-06-25       Impact factor: 3.464

6.  Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.

Authors:  Carolina F Ruivo; Nuno Bastos; Barbara Adem; Ines Batista; Cecilia Duraes; Carlos A Melo; Stephanie A Castaldo; Francisco Campos-Laborie; Pedro Moutinho-Ribeiro; Barbara Morão; Ana Costa-Pinto; Soraia Silva; Hugo Osorio; Sergio Ciordia; Jose Luis Costa; David Goodrich; Bruno Cavadas; Luisa Pereira; Tony Kouzarides; Guilherme Macedo; Rui Maio; Fatima Carneiro; Marília Cravo; Raghu Kalluri; Jose Carlos Machado; Sonia A Melo
Journal:  Gut       Date:  2022-01-10       Impact factor: 31.793

7.  Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.

Authors:  Ananda Kumar Kanduluru; Madduri Srinivasarao; Philip S Low
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

8.  Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism.

Authors:  Nami Ito; Momoko Yamada; Koichi Morishita; Satoshi Nojima; Kei Motooka; Natsumi Sakata; Tatsuya Asuka; Ryoji Otsu; Shinji Takamatsu; Yoshihiro Kamada; Soichiro Mori; Hirofumi Akita; Hidetoshi Eguchi; Eiichi Morii; Eiji Miyoshi
Journal:  Glycoconj J       Date:  2021-02-01       Impact factor: 2.916

9.  Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression.

Authors:  Ralph Francescone; Débora Barbosa Vendramini-Costa; Janusz Franco-Barraza; Jessica Wagner; Alexander Muir; Allison N Lau; Linara Gabitova; Tatiana Pazina; Sapna Gupta; Tiffany Luong; Dustin Rollins; Ruchi Malik; Roshan J Thapa; Diana Restifo; Yan Zhou; Kathy Q Cai; Harvey H Hensley; Yinfei Tan; Warren D Kruger; Karthik Devarajan; Siddharth Balachandran; Andres J Klein-Szanto; Huamin Wang; Wafik S El-Deiry; Matthew G Vander Heiden; Suraj Peri; Kerry S Campbell; Igor Astsaturov; Edna Cukierman
Journal:  Cancer Discov       Date:  2020-10-30       Impact factor: 39.397

Review 10.  KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism.

Authors:  Isaac James Muyinda; Jae-Gwang Park; Eun-Jung Jang; Byong-Chul Yoo
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.